• The 20th Annual BioCity Symposium: Viruses as enemies and friends in Turku, Finland, August 19-20, 2010
• Infektiopäivät in Helsinki, Finland, August 24-25, 2010
• The 27th Annual Meeting of Scandinavian Society for Antimicrobial Chemotherapy (SSAC) in Stockholm, Sweden, September 30 – October 3, 2010
• Laboratoriolääketiede ja näyttely 2010 in Helsinki, Finland, October 7-8, 2010
• Lastenlääkäripäivät in Oulu, Finland, November 11-12, 2010
• ESCV (European Society for Clinical Virology) Winter Meeting in London, United Kingdom, January 13-15, 2011
• Labquality Days & Exhibition 2011 in Helsinki, Finland, February 10-11, 2011
• 29th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID) in The Hague, The Netherlands, June 7-11, 2011

You are welcome to visit us at the exhibitions!

On April 2010 ArcDia declared a CE marking of the mariPOC^® analyser, also known as ArcDia™ AD7 Plate Reader with dispensing unit, according to EMC and Low Voltage Directives. ArcDia™ AD7 Plate Reader serie represents the newest microfluorometer generation by ArcDia. For more information about the products please contact ArcDia International Oy Ltd. Contact information.

ArcDia influenza A virus test

• simple workflow
• short hands-on-time
• automated results read-out
• quantitative detection
• sensitivity and specificity similar to laboratory methods
• high sensitivity for different influenza A virus subtypes
• suitable for high-throughput screening in batch mode and single sample analysis in random-access mode

• Finnish Virology Meeting 2010, Turku, Finland, March 18-19, 2010;
• 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, April 10-13, 2010 (booth #109);
• 28th European Society for Paediatric Infectious Diseases (ESPID), Nice, France, May 4-8, 2010 (booth #08);

Welcome to meet us at the exhibitions to find out more about the ArcDia’s new rapid multianalyte respiratory infection test system!

ArcDia™ Plate Reader

On December 29th 2009 ArcDia declared a CE marking of the ArcDia™ AD7 Plate Reader according to EMC and Low Voltage Directives. ArcDia™ AD7 Plate Reader represents the newest microfluorometer generation by ArcDia. For more information about the products please contact ArcDia International Oy Ltd. Contact information.

ArcDia™ Plate Reader

The analytes are:

• Influenza A virus
• Influenza B virus
• RS-virus
• Parainfluenza 1 virus
• Parainfluenza 2 virus
• Parainfluenza 3 virus
• Metapneumovirus
• Adenovirus
• S. pneumoniae
• Streptococcus Group A

The test procedure:

1. take a nasal swab sample
2. cut the swab in a test tube
3. add 1 mL of RTI sample buffer
4. vortex 10-15 sec
5. type the patient information to the ArcDiagnoser software
6. insert the sample tube in the analyzer
7. start the measurement
8. view or print automated results from 20 min and 2 h timepoints

This test system will be launched in the beginning of 2010.

The test system will be CE marked for IVD use.

ArcDia is developing a new multianalyte immunoassay test platform for rapid point-of-care testing of infectious diseases (available in 2010). The platform comprises of an automated random-access analyser and a set of test reagents.

The first test products are targeted for respiratory tract infections. According to the new test methods, nasal/throat swab samples from the patient are subjected to automated multianalyte immonassay testing, including ten common respiratory pathogens:

1. Group A streptococci
2. Streptococcus pneumoniae
3. Influenza A virus
4. Influenza B virus
5. Parainfluenza virus 1
6. Parainfluenza virus 2
7. Parainfluenza virus 3
8. Adenovirus
9. Respiratory syncytical virus
10. Human Metapneumovirus

The nasal/throat swab samples are treated with sample solution and then inserted into the bench-top analyser for multianalyte detection. The strip contains 10 parallel reaction wells, one well per test, each well containing pathogen specific assay reagents in the dry state. The analyser reports positive samples within 20 minutes of incubation. Low positive and negative samples are reported within 2 hours.

ArcDia concept for respiratory infections enables rapid point-of-care identification of respiratory infection pathogens. The system is suitable for testing of both pharyngitis, lower and upper respiratory tract infections. Viral infections do not usually need antibiotic medication and, hence, empirical antibiotic treatment may be avoided in many patients cases. Positive viral test results help rationalize the use of influenza virus -specific drugs.